Cytochromes P450 metabolize arachidonic acid (AA) to epoxyeicosatrienoic acids (EETs) which affect renal and cardiovascular functions. Current research involves: (1) characterization of CYP2J subfamily P450s at the biochemical/molecular levels; (2) studies on the regulation of CYP2J expression; (3) evaluation of the functional roles of CYP2J products in cell/organ physiology; and (4) examination of this pathway in animal models of disease (ischemic heart disease, hypertension and atherosclerosis). We have discovered a number of mammalian CYP2J subfamily members, although we have focused most of our efforts on human CYP2J2 and mouse CYP2J5. The human CYP2J2 cDNA has been cloned, expressed and characterized with respect to its tissue distribution, cellular localization and function. This enzyme is the major human P450 expressed in heart and vasculature, where it is localized to cardiac myocytes and endothelial cells, and is active in the metabolism of AA to EETs. 11,12-EET improves cardiac function following global ischemia, causes hyperpolarization of the resting membrane potential, preserves papillary muscle contraction, lengthens the time to onset of electrical uncoupling during ischemia and inhibits cardiac L-type Ca++ channel activity. 11,12-EET attenuates TNF -induced VCAM-1 expression in endothelial cells via a mechanism involving inhibition of NF- B and attenuates endothelial hypoxia-reoxygenation injury. CYP2J2 transgenic mice have been developed to study the effects of increased EETs on cardiac function in vivo. The human CYP2J2 gene has been cloned, sequenced and characterized. We have identified several CYP2J2 polymorphic variants that result in amino acid substitutions and affect catalytic efficiency. We have cloned the mouse Cyp2j5 gene, expressed the recombinant protein and shown that it catalyzes the biosynthesis of EETs. CYP2J5 is abundant in the kidney and localized to proximal tubules and collecting ducts, sites where EETs modulate salt/water transport and mediate the actions of renal hormones. Renal CYP2J5 expression is up-regulated by androgens, down-regulated by estrogens and developmentally regulated. CYP2J expression and EET biosynthesis are increased in spontaneously hypertensive rats. Cyp2j5 deficient mice have been developed to study the functional significance of this P450 in kidney development, renal physiology and blood pressure regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES025034-06
Application #
6432280
Study Section
(LPP)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2000
Total Cost
Indirect Cost
Name
U.S. National Inst of Environ Hlth Scis
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Lafite, Pierre; André, François; Graves, Joan P et al. (2018) Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2. Int J Mol Sci 19:
Edin, Matthew L; Hamedani, Behin Gholipour; Gruzdev, Artiom et al. (2018) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia. J Biol Chem 293:3281-3292
Hagar, Jon A; Edin, Matthew L; Lih, Fred B et al. (2017) Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock. J Immunol 199:3634-3643
Graves, Joan P; Gruzdev, Artiom; Bradbury, J Alyce et al. (2017) Characterization of the Tissue Distribution of the Mouse Cyp2c Subfamily by Quantitative PCR Analysis. Drug Metab Dispos 45:807-816
Hasegawa, Eiichi; Inafuku, Saori; Mulki, Lama et al. (2017) Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization. Proc Natl Acad Sci U S A 114:E7545-E7553
Garcia, Victor; Gilani, Ankit; Shkolnik, Brian et al. (2017) 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension. Circ Res 120:1776-1788
Hanif, Ahmad; Edin, Matthew L; Zeldin, Darryl C et al. (2017) Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A2A receptor and plasma oxylipins. Prostaglandins Other Lipid Mediat 131:83-95
Hoopes, Samantha L; Gruzdev, Artiom; Edin, Matthew L et al. (2017) Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice. PLoS One 12:e0175348
Bettaieb, Ahmed; Koike, Shinichiro; Hsu, Ming-Fo et al. (2017) Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia. Biochim Biophys Acta Gen Subj 1861:2758-2765
Bettaieb, Ahmed; Koike, Shinichiro; Chahed, Samah et al. (2017) Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. FEBS J 284:1970-1986

Showing the most recent 10 out of 138 publications